Both in Pharmaceuticals
ADARx Pharmaceuticals vs SELLAS Life Sciences Group
Over the past year ADRX returned −22.9% and SLS returned −30.8%; their daily moves had a correlation of 0.20.
ADRX −22.9% SLS −30.8%Growth of $1, one year, split-adjusted
| Metric | ADRX | SLS |
|---|---|---|
| Price | $14.91 | $8.03 |
| Market cap | $1.59B | $1.62B |
| Today | +12.11% | −4.63% |
| 1 month | −16.4% | −32.4% |
| 6 months | — | +8.2% |
| Year to date | — | +113.0% |
| 1 year | — | +431.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 100.1% |
| Short % of float | 3.4% | 28.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).